In prostate cancer, in vitro activation of TLR4 by LPS promoted proliferation and survival of prostate epithelial PC3 cancer cells through the VEGF and TGF-β dependent pathways [13], while TLR4 silencing via small interfering RNA showed the opposite effect [14]. Here, TGFB1 is linked to prostate carcinoma.